VeriMomtetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
Pregnancy-safe products containing tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate
Related ingredients
Frequently asked questions
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate emzirirken güvenli mi?
- No data located showing lactational transfer, mammary toxicity, or reproductive system effects. No SCCS/CIR opinion or harmonised hazard for this ingredient. Therefore default hazard/mechanism = 0 and exposure from topical cosmetic use is considered negligible based on peptide structure and marketed aqueous/glycerin formulations. Sources: DSM Syn‑HYCAN product literature, EPA CompTox, PubMed search (no relevant studies found).
- tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate bebek cildi için güvenli mi?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- VeriMom tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate nasıl puanlıyor?
- VeriMom tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.